Health Equity in Focus

When Pfizer and other major corporations drafted the rules that became the WTO’s Agreement on Trade-Related Aspects of Intellectual Property (TRIPS), they set global standards that still determine who gets affordable medicines and who doesn’t. Today, those rules are even more evident through the announcement of Trump's tariff deals. Countries are rushing to Washington following the 2 April 20...

For years, Africa grappled with a steady rise in mpox cases and recurring outbreaks, yet the disease remained largely overlooked by the global community. It was only when the virus reached Northern countries that mpox began to garner international attention. This long-standing neglect is evident in the sparse data on the disease, the minimal investment in research and development of medical counte...

In our inaugural episode, we explore the recent amendments to the International Health Regulations (IHR) and their implications for developing countries, particularly in light of the upcoming session of the Intergovernmental Negotiating Body (INB) negotiating a Pandemic Instrument.  The IHR amendments represent a pivotal step towards recognizing the historical inequalities that have long plagued g...